High
osteopontin (OPN) expression is linked to
breast cancer bone
metastasis. In this study we modulated
osteopontin levels conditionally and investigated any related
antineoplastic effects. Therefore, we established cell clones from human
breast cancer MDA-MB-231 cells, in which the expression of OPN is regulated by the Tet-Off tet-off system. These cells, which conditionally express a specific
miRNA targeting OPN, were used for in vitro studies as well as for a bone
metastasis model in nude rats. Changes in whole-genome expression elicited by conditional OPN knockdown and vesicle formation were also analyzed. The alkylphosphocholine
erufosine was used for combination
therapy. Conditional OPN knockdown caused mild anti-proliferative, but more intensive anti-migratory and anti clonogenic effects, as well as partial and complete remissions of soft tissue and osteolytic lesions. These effects were associated with specific gene and
protein expression modulations following
miRNA-mediated OPN knockdown. Furthermore, high levels of OPN were detected in vesicles derived from rats harboring
breast cancer skeletal
metastases. Finally, the combination of OPN inhibition and
erufosine treatment caused an additive reduction of OPN levels in the investigated
breast cancer cells. Thus, knockdown of OPN alone or in combination with
erufosine is a promising strategy in
breast cancer skeletal
metastasis treatment.